Evidence implicating complement in AD emerged in the 1980s; immunostaining of brain tissue showed C1q, C3, factor H (FH), and clusterin colocalising with Aβ plaques and surrounding sites of neuronal damage [11, 12]. The gene discussed is CLU; the disease is Alzheimer disease.